StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) : vimarsana.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the stock. TherapeuticsMD Stock Performance NASDAQ TXMD opened at $2.27 on Thursday. TherapeuticsMD has a 52-week low of $1.95 and a 52-week high of $5.40. The company has a 50-day […]

Related Keywords

United States , Marland Walker , Mayne Pharma , Therapeuticsmd Company Profile , Jpmorgan Chase Co , Therapeuticsmd Inc , Renaissance Technologies , Securities Exchange Commission , Principal Financial Group Inc , Free Report , Get Free Report , Exchange Commission , Financial Group , State Street Corp , Street Corp , Therapeuticsmd , Nasdaq Txmd , Txmd , Medical , Initiated Coverage , Stocknews Com ,